Home »
International Business
Axigen Healthcare aspires to become one of the most respected, profitable and integrated global pharmaceutical company that delivers international standards on all counts.
In order to achieve this objective, we have a special focus towards anticipating trends in the emerging markets (which hold the maximum potential) of African Countries like Zimbabwe, Kenya, Uganda, Nigeria, Ghana and Tanzania; Asian Countries like Sri Lanka, Vietnam, Myanmar, Philippines, Malaysia, Nepal and Bangladesh; Middle East Region like Bahrain, UAE, Oman Yemen and Lebanon as well as reviewing the demands of the developed markets.
Along with these focus markets, we are also trying to tap the Russian & CIS markets and US market with selected product portfolio, which include complex technology products to get the competitive advantage in the market place. We expect US market to be our key growth driver in the coming years.
Through contract manufacturing and active product registrations, we are focused towards formulation development and have a plan for strong back up in terms of R&D and aggressive marketing. Axigen have innovative product range offerings through exclusive tie-ups, supply and marketing arrangements.
The company has planned remarkable growth across markets. Starting with exports to emerging markets, the company has believed that we will successfully penetrate into the regulated markets.
Our Geographical Reach
Emerging markets is a mix of regulated and semi regulated markets comprising of Russia, CIS, South East Asia, Asia Pacific, Africa and Middle East. Axigen Healthcare’s focus products in the therapeutic areas like Gynaecology, Infertility Management, Science-based Nutritional Health, Dermatology, Gastroenterology, Pain Management and Acute care.